126 related articles for article (PubMed ID: 38058256)
21. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Kiss T; Jámbor K; Koroknai V; Szász I; Bárdos H; Mokánszki A; Ádány R; Balázs M
Pathol Oncol Res; 2021; 27():581395. PubMed ID: 34257527
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.
Sarosiek K; Jones E; Chipitsyna G; Al-Zoubi M; Kang C; Saxena S; Gandhi AV; Sendiky J; Yeo CJ; Arafat HA
J Gastrointest Surg; 2015 Apr; 19(4):639-50. PubMed ID: 25583441
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
Ferreira LB; Eloy C; Pestana A; Lyra J; Moura M; Prazeres H; Tavares C; Sobrinho-Simões M; Gimba E; Soares P
Eur J Endocrinol; 2016 Apr; 174(4):551-61. PubMed ID: 26811408
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
27. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin.
Kale S; Raja R; Thorat D; Soundararajan G; Patil TV; Kundu GC
Oncogene; 2014 May; 33(18):2295-306. PubMed ID: 23728342
[TBL] [Abstract][Full Text] [Related]
28. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
29. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
30. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
[TBL] [Abstract][Full Text] [Related]
31. OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.
Ferreira LB; Lima RT; Bastos ACSDF; Silva AM; Tavares C; Pestana A; Rios E; Eloy C; Sobrinho-Simões M; Gimba ERP; Soares P
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274371
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.
Tang X; Li J; Yu B; Su L; Yu Y; Yan M; Liu B; Zhu Z
Int J Biol Sci; 2013; 9(1):55-66. PubMed ID: 23289017
[TBL] [Abstract][Full Text] [Related]
33. Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts.
Ota D; Kanayama M; Matsui Y; Ito K; Maeda N; Kutomi G; Hirata K; Torigoe T; Sato N; Takaoka A; Chambers AF; Morimoto J; Uede T
J Mol Med (Berl); 2014 Dec; 92(12):1271-81. PubMed ID: 25099519
[TBL] [Abstract][Full Text] [Related]
34. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways.
Gimba ER; Tilli TM
Cancer Lett; 2013 Apr; 331(1):11-7. PubMed ID: 23246372
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance.
Mirzaei A; Mohammadi S; Ghaffari SH; Yaghmaie M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):615-623. PubMed ID: 29580029
[TBL] [Abstract][Full Text] [Related]
37. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site.
Nishimichi N; Higashikawa F; Kinoh HH; Tateishi Y; Matsuda H; Yokosaki Y
J Biol Chem; 2009 May; 284(22):14769-76. PubMed ID: 19346516
[TBL] [Abstract][Full Text] [Related]
38. Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry.
Wu J; Pungaliya P; Kraynov E; Bates B
Biomarkers; 2012 Mar; 17(2):125-33. PubMed ID: 22188260
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
Wohlleben G; Hauff K; Gasser M; Waaga-Gasser AM; Grimmig T; Flentje M; Polat B
Oncol Rep; 2018 Jan; 39(1):442-448. PubMed ID: 29115557
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
Brum MCM; Dos Santos Guimaraes I; Ferreira LB; Rangel LBA; Maia RC; Nestal De Moraes G; Gimba ERP
Oncol Rep; 2021 Feb; 45(2):652-664. PubMed ID: 33416171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
